Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Molecular targeted therapy for neuroimmunological diseases].
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes.
Serum proteomics in multiple sclerosis disease progression.
The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Gene flow from North Africa contributes to differential human genetic diversity in southern Europe.
Generation and preclinical characterization of an antibody specific for SEMA4D.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
Ipilimumab in patients with melanoma and autoimmune disease.
Pages
« first
‹ previous
…
590
591
592
593
594
595
596
597
598
…
next ›
last »